Digital Color Doppler Ultrasound System (Autra RS, Autra 90, Autra Senior, Autra CV, e-Autra, Autra 75, Autra 85W, Autra 65, Autra 55, Autra 65i, Autra 90 Elite, Autra 85 Elite, Autra 80 Elite, Autra 75 Elite, Autra 85 CV, Autra 80W, Autra 65 Elite, Autra 55 Elite, Autra 55i, Autra 90 CV, Autra 85, Autra 80, Autra 80 CV, Autra 75 Pro, Autra 75W, Autra 70 Elite, Autra 70, Autra T)
SONOSCAPE MEDICAL CORP. · Decision date May 15, 2026
What did the FDA decide?
FDA records K254028 as a 510(k) premarket notification, with a decision dated May 15, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- May 15, 2026
Regulatory record facts
- Identifier
- K254028
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- SONOSCAPE MEDICAL CORP.
- Product code
- IYN
- Decision code
- SESE
- Decision date
- May 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.
- Applicant
- SONOSCAPE MEDICAL CORP.
- Product code
- IYN
- FDA device class
- 2
FDA decision timeline
K254028 received
Application receipt date recorded by FDA.
K254028 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| GE Medical Systems Ultrasound and Primary care Diagnostics, LLC | 510(k) clearance | Oct 2, 2026 | FDA | |
| Philips Ultrasound, LLC | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
SONOSCAPE MEDICAL CORP.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K254028
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


